DIONE ROWE: Open Payments
NPI 1174862924 · WINNER, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$58,776 in 134 payments from 10 companies in 2025. Trend: 2023 $37,998 · 2024 $31,609 · 2025 $58,776
Speaker / faculty: $36,148Travel & lodging: $10,353Consulting: $9,746Food & beverage: $2,525Education: $4
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 73 | $46,442 |
| Alkermes, Inc. | 35 | $11,857 |
| ABBVIE INC. | 5 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $78 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| E.R. Squibb & Sons, L.L.C. | 4 | $71 |
| Teva Pharmaceuticals USA, Inc. | 4 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $56 |
| Vanda Pharmaceuticals Inc. | 2 | $39 |
| Janssen Pharmaceuticals, Inc | 1 | $24 |
Products named: INGREZZA, LYBALVI, ARISTADA, VRAYLAR, CAPLYTA, Auvelity, COBENFY, Jornay PM.
Industry payments across SD — which companies pay providers there.
